BackTransmedics Group Overview

Transmedics Group Research & Development

Get informed when a big investor buys or sells

+ Follow

Quarterly R&D Expenses

$31.63M
98.52% YoY

As of Jun 30, 2026

Annual R&D Expenses (TTM)

$92.47M
44.89% YoY

Trailing 12 months ending Jun 30, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Transmedics Group (TMDX) FAQ

Stockcircle tracks research & development for Transmedics Group (TMDX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Research & Development page is built for Transmedics Group's historical R&D spending trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use R&D spending as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main TMDX overview so you can move from this figure to the surrounding analysis quickly.